<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-vaccines-08-00307">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khanam</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pilankatta</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Khanna</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Swaminathan</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity</article-title>
  <source>Vaccine</source>
  <year>2009</year>
  <volume>27</volume>
  <fpage>6011</fpage>
  <lpage>6021</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.07.073</pub-id>
  <pub-id pub-id-type="pmid">19665609</pub-id>
 </element-citation>
</ref>
